Tuesday, March 10, 2026
spot_img
HomeNews

News

CStone and Pfizer Announce NMPA Approval of Sugemalimab in Patients With Unresectable Stage Iii Non-small Cell Lung Cancer

CStone Pharmaceuticals, a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Pfizer Inc. announced that...

One Drop Study Signals Significant Growing Interest in Continuous Glucose Monitors (CGMs) Among People with Type 2 Diabetes (T2D)

One Drop, a leader in precision health solutions for people living with diabetes and other chronic conditions, presented new research at the 82nd Scientific...

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

TransMedics Group, Inc., a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced that...

BD Unveils World’s First Spectral Cell Sorter with High-Speed Imaging Technology

BD (Becton, Dickinson and Company), a leading global medical technology company, announced it will introduce new cell sorting technology at the International Society for...

Diabeloop and SOOIL Development Company Announce Global Development

ADA 2022 - On the occasion of the 2022 American Diabetes Association Scientific Sessions, Diabeloop, a leader in therapeutic AI applied to insulin...

Hot Topics

spot_img